15-22The work investigates the development and optimization of ionotropically-gelled mucoadhesive beads composed of tamarind seed polysaccharide (TSP)-alginate polymer-blend for oral delivery of metformin HCl using 32 factorial design. The optimized mucoadhesive beads exhibited 94.86 ± 3.92 % drug encapsulation efficiency and good mucoadhesivity with the biological membrane in wash-off test, and sustained drug release profile over 10 h. The in vitro drug release from these beads was followed controlled-release (zero-order) pattern (R2 = 0.9873 to 0.9980) with super case-II transport mechanism. The optimized TSPalginate mucoadhesive beads containing metformin HCl showed significant antidiabetic effect in alloxan-induced diabetic ra...
The metabolic disorder type 2 diabetes mellitus continuously increasing in the world. This disorder ...
Metformin is a biguanide antihyperglycemic agent and first-line pharmacotherapy used in the manageme...
Abstract The aim of the current study is to design a sustained release matrix tablet of metformin HC...
Mucoadhesive tablets is the preferable route of drug delivery due to the ease of administration, pat...
Purpose: To prepare metformin HCl-loaded alginate (AL) and alginate-chitosan (AL-CS) beads for oral ...
Mucoadhesive microspheres were found to be more efficient for controlled drug delivery. Mucoadhesion...
Metformin HCL, the only biguanide still in use today, reduces peripheral insulin resistance and hepa...
The aim of the proposed study is to develop a mucoadhesive buccal delivery system for the sustained ...
Purpose: To investigate the effect of drug and polymer ratio on the physical characteristics and rel...
Alginate microspheres for a highly water soluble antidiabetic drug Metformin hydrochloride was prepa...
We developed a dual microencapsulation platform for the type 2 diabetes drug metformin (MTF), which ...
We developed a dual microencapsulation platform for the type 2 diabetes drug metformin (MTF), which ...
Metformin hydrochloride is an antidiabetic agent which improves glucose tolerance in patients with t...
Many approaches have been immerged to prolong the residence time of the dosage forms at the absorpti...
Alginate microspheres with metformin hydrochloride were prepared by the spray drying method in order...
The metabolic disorder type 2 diabetes mellitus continuously increasing in the world. This disorder ...
Metformin is a biguanide antihyperglycemic agent and first-line pharmacotherapy used in the manageme...
Abstract The aim of the current study is to design a sustained release matrix tablet of metformin HC...
Mucoadhesive tablets is the preferable route of drug delivery due to the ease of administration, pat...
Purpose: To prepare metformin HCl-loaded alginate (AL) and alginate-chitosan (AL-CS) beads for oral ...
Mucoadhesive microspheres were found to be more efficient for controlled drug delivery. Mucoadhesion...
Metformin HCL, the only biguanide still in use today, reduces peripheral insulin resistance and hepa...
The aim of the proposed study is to develop a mucoadhesive buccal delivery system for the sustained ...
Purpose: To investigate the effect of drug and polymer ratio on the physical characteristics and rel...
Alginate microspheres for a highly water soluble antidiabetic drug Metformin hydrochloride was prepa...
We developed a dual microencapsulation platform for the type 2 diabetes drug metformin (MTF), which ...
We developed a dual microencapsulation platform for the type 2 diabetes drug metformin (MTF), which ...
Metformin hydrochloride is an antidiabetic agent which improves glucose tolerance in patients with t...
Many approaches have been immerged to prolong the residence time of the dosage forms at the absorpti...
Alginate microspheres with metformin hydrochloride were prepared by the spray drying method in order...
The metabolic disorder type 2 diabetes mellitus continuously increasing in the world. This disorder ...
Metformin is a biguanide antihyperglycemic agent and first-line pharmacotherapy used in the manageme...
Abstract The aim of the current study is to design a sustained release matrix tablet of metformin HC...